AbbVie Inc. (ABBV) Gross margin 2016–2025
AbbVie Inc. (ABBV) gross margin by fiscal year — reported gross profit divided by reported revenue.
70.2%FY2025 · since FY2016: 77.3% → 70.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 70.2% | +0.2 pp |
| FY2024 | 70.0% | +7.6 pp |
| FY2023 | 62.4% | -7.6 pp |
| FY2022 | 70.0% | +1.0 pp |
| FY2021 | 69.0% | +2.5 pp |
| FY2020 | 66.4% | -11.2 pp |
| FY2019 | 77.6% | +1.2 pp |
| FY2018 | 76.4% | +1.4 pp |
| FY2017 | 75.0% | -2.2 pp |
| FY2016 | 77.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABBV financial trends
ABBV RevenueABBV Net incomeABBV Net marginABBV Gross profitABBV Operating incomeABBV Operating marginABBV Operating cash flowABBV Free cash flowABBV Capital expendituresABBV Return on equityABBV Stock buybacksABBV Dividends paidABBV Total assetsABBV Total liabilitiesABBV Shareholders’ equityABBV overview →